Interleukin-6 (IL-6) Functions as an Autocrine Growth Factor in Cervical Carcinomas in Vitro

Gynecologic Oncology

Volumn 50, Issue 1, 1993, Pages 15-19

  Eustace, Damian ^a   Han, Xin ^b   Gooding, Roger ^c   Rowbottom, Anthony ^c   Riches, Pam ^c   Heyderman, Eadie ^b  

^a Endoscopy Training Centre   (United Kingdom)

^b Guy'S king'S St Thomas' Medical School   (United Kingdom)

^c CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; NEUTRALIZING ANTIBODY;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; TUMOR GROWTH; UTERINE CERVIX CARCINOMA;

CARCINOMA; CELL DIFFERENTIATION; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CERVIX NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GROWTH SUBSTANCES; HUMAN; IMMUNE SERA; INTERLEUKIN-6; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED;

EID: 0027303024     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1006/gyno.1993.1156     Document Type: Article

References (28)

1. Goustin, A. S., Leof, E. B., Shipley, G. D., and Moses, H. L. Growth factors and cancer, Cancer Res. 46, 1015-1029 (1986).
2. Folkman, J., Watson, K., Ingber, D., and Hanahan, D. Induction of angiogenesis during the transition from hyperplasia to neoplasia, Nature 339, 58-61 (1989).
3. Young, D. C., and Griffin, J. D. Autocrine secretion of GM-CSF in acute myeloblastic leukemia, Blood 68, 1178-1181 (1986).
4. Balkwill, F. R., Burke, F., Talbot, D., Tavernier, J., Osborne, R., Naylor, S., Durbin, H., and Fiers, W. Evidence for tumour necrosis factor/cachectin production in cancer, Lancet 2, 1229-1232 (1987).
5. Garrett, I. R., Durie, B. G. M., Nedwin, G. E., Gillespie, A., Bringman, T., Sabatini, M., Bertolini, D. R., and Mundy, G. R. Production of lymphotoxin, a bone-resorbing cytokine by cultured human myeloma cells, N. Engl. J. Med. 317, 526-532 (1987).
6. Griffin, J. D., Rambaldi, A., Vellenga, H., Young, D. C., Os-tapovicz, D., and Cannistra, S. A. Secretion of interleukin 1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors, Blood 70, 1218-1221 (1987).
7. Hirano, T., Taga, T., Nakano, N., Yasukawa, K., Kashiwamura, S., Shimizu, K., Nakajima, K., Pyun, K. H., and Kishimoto, T. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2), Proc. Natl. Acad. Sei. USA 82, 5490-5494 (1985).
8. Takai, Y., Wong, G. G., Clark, S. C., Burakoff, S. J., and Herrmann, S. H. B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes, J. Immunol. 140, 508-512 (1988).
9. Gauldie, J., Richards, C., Harnish, D., Lansdorp, P., and Baumann, H. Interferon β2/β-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells, Proc. Natl. Acad. Sei. USA 84, 7251-7255 (1987).
10. Weissenbach, J., Chemajovsky, Y., Zeevi, M., Shulman, L., Soreq, H., Nir, U., Wallach, D., Perricaudet, M., Tiollais, P., and Revel, M. Two interferon mRNAs in human fibroblasts: In vitro translation and Escherichia coli cloning studies, Proc. Natl. Acad. Sei. USA 77, 7152-7156 (1980).
11. Van Damme, J., Opdenakker, J. G., Simpson, R. J., Rubira, M. R., Cayphas, S., Vink, A., Billiau, A., and Van Snick, J. Identification of the human 26K protein (IFN-β2) as a β-cell hybri-doma/plasmacytoma growth factor induced by interleukin-1 and tumor necrosis factor, J. Exp. Med. 165, 914-919 (1987).
12. Astaldi, G. C. B., Janssen, M. C., Lansdorp, P., Willems, C., Zeijlemaker, W. P., and Oosterhof, F. Human endothelial culture supernatant (HECS): A growth factor for hybridomas, J. Immunol. 125, 1411-1414 (1980).
13. Oster, W., Cicco, N. A., Klein, H., Hirano, T., Kishimoto, T., Lindemann, A., Mertelsmann, R. H., and Herrmann, F. Participation of the cytokines interleukin 6, tumor necrosis factor-a and Interleukin 1-β secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control, J. Clin. Invest. 84, 451-457 (1989).
14. Yee, C., Biondi, A., Wang, X. H., Iscove, N. N., de Sousa, J., Aarden, L. A., Wong, G. G., Clark, S. C., Messner, H. A., and Minden, M. D. A possible autocrine role for interleukin-6 in two lymphoma cell lines, Blood 74, 798-804 (1989).
15. Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., Kuramoto, A., and Kishimoto, T. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas, Nature 332, 83-85 (1988).
16. Miki, S., Iwano, M., Miki, Y., Yamamoto, M., Tang, B., Yo-kokawa, K., Sonada, T., Hirano, T., and Kishimoto, T. Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas, FEBS Lett. 250, 607-610 (1989).
17. Stanley, M. A., and Parkinson, E. K. Growth requirements of human epithelial cells in culture, Int. J. Cancer 24, 407-411 (1979).
18. Stanley, M. A., and Dahlenburg, K. The effect of choleragen and epidermal growth factor on proliferation and maturation in vitro on human ectocervical cells, In Vitro 20, 144 (1984).
19. Han, X., Lyle, R., Eustace, D. L. S., Jewers, R. J., Parrington, J. M., Das, A., Chana, T., Dagg, B., Money, S., Bates, T. D., Kenney, A., and Heyderman, E. XH1-A new cervical carcinoma cell line and xenograft model of tumour invasion, “metastasis” and regression, Br. J. Cancer 64, 645-654 (1991).
20. Wong, Z., Wilson, V., and Jeffreys, A. J. Cloning a selected fragment from a human DNA ‘fingerprint’: Isolation of an extremely polymorphic minisatellite, Nucleic Acids Res. 14, 4605 (1988).
21. Wong, Z., Wilson, V., Patel, I., Povey, S., and Jeffreys, A. Characterisation of a panel of highly variable minisatellites cloned from human DNA, Ann. Hum. Genet. 51, 269 (1987).
22. Patillo, R. A., Hussa, R. O., Story, M. T., Ruckert, A. C. F., Shalaby, M. R., and Mattingly, R. F. Tumor antigen and human chorionic gonadotropin in CaSki cells: A new epidermoid cervical cancer cell line, Science 196, 1456-1458 (1977).
23. Giard, D. J., Aaronson, S. A., and Todaro, G. J. In vitro cultivation of human tumors: Establishment of cell lines derived form a series of solid tumors, J. Natl. Cancer Inst. 51, 1417-1423 (1973).
24. Greenwood, F. C., Hunter, W. M., and Glover, J. S. The preparation of 131I-labelled human growth hormone of high specific radioactivity, Biochem. J. 89, 114-120 (1963).
25. Aarden, L. A., De Groot, E. R., Schaap, O. L., and Lansdrop, P. M. Production of hybridoma growth factor by human monocytes, Eur. J. Immunol. 17, 1411 (1987).
26. Yamasaki, K., Taga, T., Hirata, Y., Yawata, H., Kawanishi, Y., Taniguchi, T., Hirano, T., and Kishimoto, T. Cloning and expression of the human interleukin-6 (BSF-2/IFNβ-2) receptor, Science 241, 825-828 (1988).
27. Scheffner, M., Munger, K., Byme, J. C., and Howley, P. M. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines, Proc. Natl. Acad. Sei. USA 88, 5523-5527 (1991).
28. Santhanam, U., Ray, A., and Sehgal, P. B. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product, Proc. Natl. Acad. Sei. USA 88, 7605-7609 (1991).